Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs

INTRODUCTION: Studies measuring the effectiveness of risk minimization measures (RMMs) submitted by pharmaceutical companies to the European Medicines Agency are part of the post-authorization regulatory requirements and represent an important source of data covering a range of medicinal products an...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazzaglia, Giampiero, Straus, Sabine M. J., Arlett, Peter, da Silva, Daniela, Janssen, Heidi, Raine, June, Alteri, Enrica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808048/
https://www.ncbi.nlm.nih.gov/pubmed/29124666
http://dx.doi.org/10.1007/s40264-017-0604-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808048/
https://www.ncbi.nlm.nih.gov/pubmed/29124666
http://dx.doi.org/10.1007/s40264-017-0604-4

Ejemplares similares